 |
|
|
| |
Pharmacokinetics of simeprevir (TMC435) in volunteers with moderate or severe hepatic impairment
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Sivi Ouwerkerk-Mahadevan,1 Alexandru Simion,2 Kurt Spittaels,2 Maria
Beumont-Mauviel2
1Janssen Research and Development, Beerse, Belgium; 2Janssen Infectious Diseases BVBA, Beerse, Belgium
|
| |
|
|
|
|
|
